Family Medicine · Garden Grove, CA
NPI
1336460914
Since 2010
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
12302 Garden Grove Blvd Ste 7
Garden Grove, CA, 92843
Phone (714) 537-4343
Groups this clinician bills Medicare through
Medicare paid, 2024
$304K
3,851 services
Medicare patients, 2024
619
Average age 75
Drug cost, 2024
$1.7M
13,738 prescriptions
Company payments, 2025
$1,664
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Timothy T Tran was code 99214 (office e&m - established), 1,965 times for 453 patients. In total Timothy T Tran billed 3,851 services in 24 codes, and Medicare paid $304K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-02-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,965 | 453 | $89.78 | $176K |
| 99213 Office E&M - Established | Office | 1,035 | 430 | $65.42 | $68K |
| G0008 Administration of influenza virus vaccine | Office | 213 | 207 | $35.02 | $7,459 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 212 | 212 | $140.18 | $30K |
| 90661 Vaccine Product | Office | 190 | 186 | $36.11 | $6,861 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 54 | 45 | $171.88 | $9,282 |
| 99497 Care Management/Coordination | Office | 44 | 44 | $62.40 | $2,745 |
| 99202 Office E&M - New | Office | 31 | 31 | $51.53 | $1,597 |
| 90656 Vaccine Product | Office | 31 | 31 | $21.90 | $679 |
| 96372 Injection Administration | Office | 23 | 12 | $11.33 | $261 |
| 99203 Office E&M - New | Office | 12 | 12 | $60.26 | $723 |
By year: 2022 $372K for 4,649 services; 2023 $313K for 3,961 services; 2024 $304K for 3,851 services.
Medicare prescription drug claims, 2024
In 2024, the drug Timothy T Tran prescribed most often to Medicare patients was Atorvastatin Calcium, with 800 prescriptions and refills. In total Timothy T Tran wrote 13,738 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 800 | 2,138 | 327 | $7,663 |
| Amlodipine Besylate Generic | 736 | 1,870 | 274 | $3,330 |
| Losartan Potassium Generic | 621 | 1,605 | 234 | $5,488 |
| Metformin Hcl Generic | 566 | 1,413 | 192 | $3,737 |
| Famotidine Generic | 329 | 645 | 125 | $2,535 |
| Triamcinolone Acetonide Generic | 328 | 358 | 153 | $3,259 |
| Azithromycin Generic | 293 | 293 | 211 | $927 |
| Tamsulosin Hcl Generic | 269 | 653 | 103 | $2,574 |
| Vascepa Icosapent Ethyl | 259 | 376 | 80 | $116K |
| Omeprazole Generic | 256 | 619 | 102 | $2,198 |
| Metoprolol Succinate Generic | 241 | 574 | 77 | $2,806 |
| Gabapentin Generic | 241 | 467 | 96 | $1,876 |
| Levocetirizine Dihydrochloride Generic | 237 | 465 | 105 | $2,370 |
| Cyclosporine Generic | 235 | 530 | 85 | $143K |
| Amoxicillin Generic | 232 | 232 | 142 | $865 |
Brand drugs: 2,113 claims; generic drugs: 11,444 claims; opioid claims: 131.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Timothy T Tran $1,664 ($1,664 in general payments such as food, travel and fees) from 13 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $314.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 7 | $314 |
| Aimmune Therapeutics, Inc. | 12 | $282 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $230 |
| Lilly USA, LLC LLY | 5 | $135 |
| Dexcom, Inc. DXCM | 1 | $130 |
| Genzyme Corporation SNY | 3 | $126 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $117 |
| Amgen Inc. AMGN | 4 | $86.99 |
| Abbvie Inc. ABBV | 4 | $86.16 |
| Vivus LLC | 3 | $66.5 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.